1652 Stock Overview
Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People’s Republic of China.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Fusen Pharmaceutical Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.91 |
52 Week High | HK$1.60 |
52 Week Low | HK$0.95 |
Beta | 0.28 |
1 Month Change | -26.02% |
3 Month Change | -33.58% |
1 Year Change | -30.00% |
3 Year Change | -81.24% |
5 Year Change | -80.04% |
Change since IPO | -64.17% |
Recent News & Updates
Recent updates
Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky
Dec 14Here's Why Fusen Pharmaceutical (HKG:1652) Can Manage Its Debt Responsibly
Sep 02Fusen Pharmaceutical (HKG:1652) Seems To Use Debt Quite Sensibly
Apr 02A Look At Fusen Pharmaceutical's (HKG:1652) Share Price Returns
Mar 06We Wouldn't Rely On Fusen Pharmaceutical's (HKG:1652) Statutory Earnings As A Guide
Feb 08Is Fusen Pharmaceutical Company Limited's (HKG:1652) Recent Price Movement Underpinned By Its Weak Fundamentals?
Jan 18Does Fusen Pharmaceutical (HKG:1652) Have A Healthy Balance Sheet?
Dec 28What You Need To Know About Fusen Pharmaceutical Company Limited's (HKG:1652) Investor Composition
Dec 07If You Had Bought Fusen Pharmaceutical (HKG:1652) Shares A Year Ago You'd Have Earned 34% Returns
Nov 20Shareholder Returns
1652 | HK Pharmaceuticals | HK Market | |
---|---|---|---|
7D | -12.5% | -0.8% | -0.6% |
1Y | -30.0% | -11.4% | -14.0% |
Return vs Industry: 1652 underperformed the Hong Kong Pharmaceuticals industry which returned -11.4% over the past year.
Return vs Market: 1652 underperformed the Hong Kong Market which returned -14% over the past year.
Price Volatility
1652 volatility | |
---|---|
1652 Average Weekly Movement | 5.4% |
Pharmaceuticals Industry Average Movement | 6.2% |
Market Average Movement | 7.3% |
10% most volatile stocks in HK Market | 14.6% |
10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 1652's share price has been volatile over the past 3 months.
Volatility Over Time: 1652's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 1,121 | Dudu Cao | https://www.fusenyy.com |
Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People’s Republic of China. The company’s product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. It also researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia.
Fusen Pharmaceutical Company Limited Fundamentals Summary
1652 fundamental statistics | |
---|---|
Market cap | HK$703.59m |
Earnings (TTM) | -HK$12.03m |
Revenue (TTM) | HK$717.44m |
0.9x
P/S Ratio-56.0x
P/E RatioIs 1652 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1652 income statement (TTM) | |
---|---|
Revenue | CN¥662.58m |
Cost of Revenue | CN¥338.18m |
Gross Profit | CN¥324.41m |
Other Expenses | CN¥335.52m |
Earnings | -CN¥11.11m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.015 |
Gross Margin | 48.96% |
Net Profit Margin | -1.68% |
Debt/Equity Ratio | 46.8% |
How did 1652 perform over the long term?
See historical performance and comparison